elatol
RN given for (2R-(2alpha,3alpha,6alpha))-isomer; has antibacterial activity; structure in first source
Networked: 5
relevant articles (0 outcomes,
2 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Colepicolo, Pio:
1 article
(01/2022)
|
2. | Dos Santos, Guilherme Senna:
1 article
(01/2022)
|
3. | Falkenberg, Miriam:
1 article
(01/2022)
|
4. | Miyasato, Patrícia Aoki:
1 article
(01/2022)
|
5. | Nakano, Eliana:
1 article
(01/2022)
|
6. | Pereira, Carlos Alberto de Bragança:
1 article
(01/2022)
|
7. | Stein, Erika Mattos:
1 article
(01/2022)
|
8. | Wright, Anthony D:
1 article
(01/2022)
|
9. | Barcellos Marini, Maíra:
1 article
(06/2018)
|
10. | Correa Ramos Leal, Ivana:
1 article
(06/2018)
|
Related Diseases
1. | Neoplasms (Cancer)
01/01/2018
- " : Elatol's identification as an eIF4A1 inhibitor with in vivo antitumor activities provides proof of principle for target-based screening against this highly promising target for cancer therapy. " 01/01/2018
- " : We found elatol is a specific inhibitor of ATP hydrolysis by eIF4A1 in vitro with broad activity against multiple tumor types. " 06/01/2018
- " In the present study, 6 sesquiterpenes (obtusol, (-)-elatol, dendoidiol, debrome-elatol, triquinane, and obtusane) isolated from Laurencia dendroidea were investigated for their cytotoxicity, using 4 cancer cell lines (U937, Jurkat, B16F10, and Colo-205). "
|
2. | Schistosomiasis (Bilharziasis)
|
3. | Mitochondrial Diseases (Mitochondrial Disease)
|
4. | Pneumonia (Pneumonitis)
|
5. | Lymphoma (Lymphomas)
|
|
Related Drugs and Biologics
Related Therapies and Procedures